Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
about
Endocannabinoids as Guardians of MetastasisPsychiatric Disorders and TRP Channels: Focus on Psychotropic DrugsDual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain ManagementInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Frontiers in pruritus research: scratching the brain for more effective itch therapyForebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formationDirect activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG).Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure.Transient receptor potential V1 regulates activation and modulation of transient receptor potential A1 by Ca2+Are sensory TRP channels biological alarms for lipid peroxidation?The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus.TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization.Identifying the integrated neural networks involved in capsaicin-induced pain using fMRI in awake TRPV1 knockout and wild-type rats.A synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts.Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus.Endovanilloids are potential activators of the trigeminovascular nocisensor complexActivation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal CortexThe endocannabinoid system: current pharmacological research and therapeutic possibilities.Role of cannabinoids in the regulation of bone remodelingParacrinicity: the story of 30 years of cellular pituitary crosstalk.TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure.Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons.Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain.Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.The complications of promiscuity: endocannabinoid action and metabolismDifferential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats.A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painN-arachidonoyl L-serine, a putative endocannabinoid, alters the activation of N-type Ca2+ channels in sympathetic neurons.The role of the endocannabinoid system in atherosclerosis.Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?Inflammatory pain: the cellular basis of heat hyperalgesia.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk.Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity.Transient receptor potential channels in pain and inflammation: therapeutic opportunities.
P2860
Q26766163-7B9BEB54-A15D-48FB-BE15-08C274C53998Q26786474-36DB4967-A55B-4068-9DB0-4203D0E128B3Q28067493-C5CEDC74-FF02-4B70-A897-90BC83F7F18AQ28298445-1154550F-2334-4005-ABB7-45AABF55688DQ30477216-D88D2816-74BF-4D57-B4E3-C4F3526A36CFQ30478061-8FDC6C85-1940-443E-866B-67D672B97E57Q30484392-75808040-1214-462D-8104-CDA1BEFC03AEQ30500199-A5E781E5-E290-4DCA-B0FE-94190E9CBD77Q34072766-53C5FD9D-1B94-441E-8648-2356F6E13A02Q34349121-CFC7D6BC-2A23-4AE8-B153-406D85D46B62Q34358689-FE03D2B8-30F8-4779-9801-F5175D2EB74DQ34587990-6DE2C1EA-1F0E-4641-AE86-EEF1ED9D95AFQ34684362-4F509FC8-4C7A-4FB4-872A-45F8AAC74552Q34698703-E360C6D5-77F8-4528-8ECB-4728B647AF55Q35057185-8DAE5D72-8FEE-49A8-A01D-37FE24D70ABEQ35099338-2C354B22-0DEB-4B5D-B91D-E7C1DB1B49DDQ35803402-5F0F5B80-A10A-4AB6-8EB9-383BE7C36FE8Q35941390-76618162-C134-41D8-95E4-A3D2B189681EQ36020582-7C8854BC-9B33-4C20-AF6B-B3922B542555Q36124954-A4FADBB5-DEB2-40AB-BC9E-44C6F5B665FAQ36300113-CEA60F56-0419-41FC-8280-0A9234A26461Q36332761-476D7514-D5E1-46B0-BE9D-9EB40377BB58Q36381416-9DC229C4-12C1-4ED9-9745-36608D562ABFQ36404379-2993D9E5-1628-4CF0-959B-EDE016C39F43Q36435897-82B2A08C-4622-43EB-AE3A-7DE7DF7F7069Q36547404-145CADF4-F0A6-478B-AE8F-2B11ABDD6BC6Q36575380-EBDD2444-481F-48A5-9337-8238570E17C6Q36734927-63441F1C-1A33-4F3D-8B46-2FBF5586A8BDQ36852186-6485D5BA-3653-4E17-BF67-21B153F5F74AQ36944706-29A2EEFD-EF1C-49C9-9CBA-A746E1686AB2Q36990238-D0B90A05-CEAE-4241-8F41-4FA0184EAE97Q37067266-3C99B6CF-02B9-4323-8156-586713547C7DQ37119534-9DF7F281-5687-4F61-AA88-508FEB35A21CQ37143578-C540D514-434D-4E4D-8C85-6C9A0BA38819Q37180517-2D4823B7-29F4-452F-8FFD-FCF9A70A163BQ37211785-685D6207-01BF-42CB-AA79-DA7731D64503Q37244823-520ED397-803D-4F29-B3EB-4F6C08F65431Q37274198-0C8FE5A4-592E-4FB4-89B0-836AD02FCEB5Q37318644-CBB0D253-7DD4-42D8-8C96-E63D768A1619Q37709505-5EA0D395-3E6B-4C89-853B-314C2A5FC787
P2860
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@ast
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@en
type
label
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@ast
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@en
prefLabel
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@ast
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@en
P2093
P2860
P50
P356
P1433
P1476
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels.
@en
P2093
Aniello Schiano Moriello
Barbara Campi
Luciano De Petrocellis
Marcello Trevisani
Mario van der Stelt
Piero Geppetti
P2860
P304
P356
10.1038/SJ.EMBOJ.7600784
P407
P577
2005-08-18T00:00:00Z